Call for Posters
|
Abstracts are being sought for the conference
entitled “Patient-Reported Outcomes Assessment in
Cancer Trials: Evaluating and Enhancing the Payoff to
Decision Making,” sponsored by the National Cancer
Institute (NCI). The conference will convene scientists
from NCI-sponsored clinical trials networks (cooperative
groups, cancer centers), government, academia, and the
private sector to examine when, where, and how the
measurement of patient-reported outcomes (PROs), such as
health-related quality of life, in cancer trials can
yield valuable information for decisions about cancer
care, third-party reimbursement, and drug approval. All
submissions will be peer-reviewed and may be accepted
for a poster presentation. New researchers and junior
faculty are encouraged to submit abstracts.
Sample topics include but are not limited to:
- Application of PRO data in treatment, symptom
management, screening, or prevention trials (Phase I,
II, III, or IV).
- Utilizing qualitative and quantitative methods to
enhancing the validity, reliability, and
interpretability of PRO measures in clinical trials.
- Assessing the value-added PROs in specific trial
contexts.
- New Technologies for Assessing PROs: Reducing Cost,
Improving Accuracy, Enhancing Acceptability.
- Policies and perspectives regarding use of PROs in
cancer clinical trials.
All abstracts must be submitted electronically no later
than midnight (Eastern Time) on July 28, 2006 (Friday).
You will be notified of its acceptance or rejection within 10 business days. Abstract submissions should be
NO LONGER THAN 250 words (not including name and
affiliation).
Please follow the instructions below to submit an
abstract for consideration.
- To submit your abstract, send it via email to John Hare jhare@scgcorp.com with "PROACT Abstract" in the subject line; attach your abstract as an MS Word document to the email along with any comments.
- The abstract should include a statement of the
problem, purpose, methods, results, and conclusions.
Please do not use these headings in the abstract.
- Ensure that titles of abstracts are typed in Title
Case Letters, are centered, and are in bold-faced type.
- List the names, degree(s) and institutional
affiliation(s) of all authors in the order of their
contribution to the presentation or research.
Information regarding the individual(s) responsible for
presenting the research must be complete and accurate so
that they can be notified of the status of the abstract.
- Italicize the name of the person presenting the
abstract.
- Make sure that your abstract is as detailed as
possible to aid in the review process.
POSTER PRESENTATIONS
Poster presentations will be displayed on 4-foot-high by
6-foot-wide poster boards. Pushpins and Velcro will be
provided onsite.
All presenters must register for the conference.
NIH/NCI contact: Dr. Bryce B. Reeve (reeveb@mail.nih.gov)
|
|
 |
|
